Aravind Eye Hospital, Chennai, India.
Eur J Ophthalmol. 2024 Jan;34(1):NP70-NP74. doi: 10.1177/11206721231174259. Epub 2023 May 15.
Idiopathic retinal vasculitis, aneurysms, and neuroretinitis (IRVAN) syndrome is a rare clinical entity affecting young healthy individuals. Treatment primarily involves pan retinal photocoagulation (PRP) to capillary non perfusion areas. Intravitreal anti-VEGF or steroids are given in the presence of macula edema. Oral steroids do not alter the course of the disease. Arterial occlusions have been reported in IRVAN.
Retrospective case review.
A twenty seven year old male presented to us with mild blurring of vision for one week. His BCVA was OU 20/20. Anterior segment examination was normal. Fundus examination showed bilateral disc aneurysm with OS arterial aneurysm along the inferior arcade. Fundhus fluorescein angiography and OCT angiography were confirmatory of the disc and retinal aneurysm. Capillary non perfusion (CNP) areas were noted in the periphery. Two days later he presented with paracentral scotoma in his left eye which was confirmed by Amsler chart. Fundus, OCT and OCTA were confirmatory of Paracentral Acute Middle Maculopathy (PAMM). The retinal aneurysm had increased in size from 333 micron diameter to 566 micron diameter. Panretinal photocoagulation to the CNP areas was done and intravitreal antiVEGF was given. At 6 months follow up, retinal aneurysm had disappeared.
Our case describes a unique event with sudden increase in size of the aneurysm leading to acute blockage in the deep capillary plexus thus being the first report of PAMM in IRVAN. The patient was treated with PRP and intravitreal anti-VEGF for the enlarging aneurysm which reduced in size within a week.
特发性视网膜血管炎、动脉瘤和神经视网膜炎(IRVAN)综合征是一种罕见的临床实体,影响年轻健康个体。治疗主要包括视网膜光凝术(PRP)以治疗毛细血管无灌注区。在存在黄斑水肿的情况下,给予玻璃体内抗 VEGF 或类固醇。口服类固醇不会改变疾病的进程。IRVAN 已报道有动脉闭塞。
回顾性病例研究。
一名 27 岁男性因一周轻度视力模糊就诊。他的双眼最佳矫正视力(BCVA)均为 20/20。眼前节检查正常。眼底检查显示双侧视盘动脉瘤,伴 OS 动脉下弓状动脉瘤。眼底荧光血管造影和 OCT 血管造影证实了视盘和视网膜动脉瘤。周边可见毛细血管无灌注(CNP)区。两天后,他左眼出现中心旁暗点,阿姆斯勒表证实。眼底、OCT 和 OCTA 证实为中心旁急性中黄斑病变(PAMM)。视网膜动脉瘤从 333 微米直径增大到 566 微米直径。对 CNP 区行全视网膜光凝,并给予玻璃体内抗 VEGF。6 个月随访时,视网膜动脉瘤已消失。
我们的病例描述了一个独特的事件,即动脉瘤突然增大导致深层毛细血管丛急性阻塞,这是 IRVAN 中首例 PAMM 报告。患者接受了 PRP 和玻璃体内抗 VEGF 治疗,以治疗增大的动脉瘤,动脉瘤在一周内缩小。